Skip to content

High Intensity Interval Training in UK Cardiac Rehabilitation Programmes

High Intensity Interval Training (HIIT) Versus Moderate Intensity Steady State Training (MISS) in UK Cardiac Rehabilitation Programmes: a Multi-centre Randomised Controlled Trial and Economic Evaluation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02784873
Acronym
HIIT-or-MISS
Enrollment
382
Registered
2016-05-27
Start date
2016-09-30
Completion date
2021-03-31
Last updated
2021-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Disease

Keywords

High intensity interval training, Coronary heart disease, Exercise training, Cardiac rehabilitation, Interval training

Brief summary

The purpose of the trial is to compare the effects of high intensity interval training (HIIT) with usual care - moderate intensity steady state training (MISS) - in UK cardiac rehabilitation (CR) programmes.

Detailed description

Current cardiac rehabilitation (CR) guidelines recommend moderate intensity, steady state exercise training (MISS). However, this guideline predates significant advances in interventional and medical treatment for coronary heart disease (CHD) and may not, therefore, be the most effective strategy for the 'modern' patient with CHD. Recent research has indicated that greater benefit may be attained by participating in high intensity interval training (HIIT) which involves repeated short bursts of harder exercise interspersed with short recovery periods. Studies suggest that this can be performed without any compromise in exercise adherence or patient safety. The benefit of this approach in 'real world' CR programmes in the UK cannot be confirmed, as studies have been predominantly conducted in the laboratory and exclusively outside the UK. In patients attending CR programmes in the UK, the investigators hypothesise that HIIT will improve VO2 peak to a greater extent than MISS. The investigators also hypothesise that HIIT will: 1) be more palatable than MISS and demonstrate greater patient compliance and adherence; 2) improve cardiovascular health to a greater extent than MISS; 3) improve HR-QoL to a greater extent than MISS; 4) lead to more positive motivation and attitudes to exercise than MISS; 5) increase short and medium-term participation in lifestyle physical activity to a greater extent than MISS; 6) be a cost effective alternative to MISS; 7) be as safe as MISS. The HIIT or MISS study is a pragmatic single-blind, multi-centre, longitudinal, randomised controlled trial. Participants will be randomly allocated to 8 weeks of HIIT or MISS (usual care). Outcomes will be assessed at baseline, 8 weeks and 12 months by assessors blinded to group allocation. Study interventions will be delivered by clinical (not research) staff.

Interventions

OTHERHigh intensity interval training

High intensity interval training within a standard cardiac rehabilitation programme

Sponsors

Cardiff Metropolitan University
CollaboratorOTHER
City Health Care Partnership CIC (Hull)
CollaboratorUNKNOWN
University of Hull
CollaboratorOTHER
Aneurin Bevan University Health Board
CollaboratorOTHER
Wake Forest University Health Sciences
CollaboratorOTHER
Bangor University
CollaboratorOTHER
University of Warwick
CollaboratorOTHER
University Hospitals Coventry and Warwickshire NHS Trust
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

General inclusion criteria: 1. Successfully revascularised following percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) 2. Angiographically documented non-obstructive coronary artery disease (CAD) 3. Left ventricular ejection fraction (LVEF) \> 40% 4. Clinically stable (symptoms and medication) for \> 2 weeks 5.18 - 75 yrs of age General

Exclusion criteria

1. Symptoms of ischemia 2. Significant left main stem stenosis 3. NYHA class III-IV symptoms 4. Compromising cardiac ventricular arrhythmia 5. Significant valvular heart disease 6. Inability to comply with guidelines for participation in exercise testing and training 7. Significant limiting comorbidities that would prevent full participation Additional

Design outcomes

Primary

MeasureTime frameDescription
Change in peak oxygen uptake (VO2 peak)Baseline, 8 weeks and 12 monthsCardiopulmonary exercise test

Secondary

MeasureTime frameDescription
Psychological factors associated with compliance and adherence (1)Baseline, 8 weeksQuantitative psychology - questionnaires: 1) the Multidimensional Self-Efficacy for Exercise Scale (MSES)
Psychological factors associated with compliance and adherence (2)Baseline, 8 weeksQuantitative psychology - questionnaires: 2) the Behavioural Regulation in Exercise Questionnaire-2 (BREQ-2)
Psychological factors associated with compliance and adherence (3)Baseline, 8 weeksQuantitative psychology - questionnaires: 3) the Psychological Need Satisfaction in Exercise Scale (PNSES)
Psychological factors associated with compliance and adherence (4)Baseline, 8 weeksQuantitative psychology - questionnaires: 4) Courneya and Bobick's 7-point bipolar adjectival rating scale;
HR-QOLBaseline, 8 weeks and 12 monthsQuestionnaire - EQ-5D-5L
Service and resource useBaseline, 8 weeks and 12 monthsQuestionnaire - client service receipt inventory (CSRI)
Compliance and adherenceEvery exercise session (8 week exercise programme duration)Compliance and adherence will be determined by recording the number of training sessions attended and successfully completed in accordance with the exercise protocol. Drop-out from the programme will also be documented for both study groups in addition to reason for drop-out, where provided voluntarily by participants.
Metabolic reserveBaseline, 8 weeks and 12 monthsCardiopulmonary exercise test - ventilatory threshold (VT)
Ventilatory efficiencyBaseline, 8 weeks and 12 monthsCardiopulmonary exercise test - slope of ratio of ventilation to carbon dioxide (VE/VC02 slope)
Cardiac remodellingBaseline, 8 weeks and 12 monthsEchocardiography - left ventricular volumes
Arterial remodellingBaseline, 8 weeks and 12 monthsArterial oscillometry - pulse wave velocity
Cardiovascular healthBaseline, 8 weeks and 12 monthsCHD risk factor assessment
Palatability8 weeksQualitative psychology - thematic analysis of semi structured interviews
Lifestyle physical activityBaseline, 8 weeks and 12 monthsPhysical activity monitor (worn for 1 week) - total energy expenditure

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026